Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma

doi:10.3748/wjg.v22.i13.3652

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8941)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-4) series.

Item

Count

PDF

580

WORD

402

HTML

4591

Figures (1-8)

274

Tables (1-4)

194

Sum=6041

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1239

Download

1661

Sum=2900

Apr 7, 2016 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Apr 7, 2016; 22(13): 3652-3662
Published online Apr 7, 2016. doi: 10.3748/wjg.v22.i13.3652

Table 3 Patients’ demographic characteristics, tumor volume, and tumor stage

Age (yr)	Gender	Diagnosis criteria	Size (cm³)	Stage (BCLC)¹
64.857 ± 10.384	Female 5	Confirmed by histology 8	409.588	A2 (2)
	Male 23	Diagnosed by EASL 20		A3 (3)
				A4 (1)
				B (11)
				C (11)

¹Barcelona-Clínic Liver Cancer classiﬁcation[13]. EASL: European Association for the Study of the Liver.

Citation: Yang JF, Zhao ZH, Zhang Y, Zhao L, Yang LM, Zhang MM, Wang BY, Wang T, Lu BC. Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma. World J Gastroenterol 2016; 22(13): 3652-3662
URL: https://www.wjgnet.com/1007-9327/full/v22/i13/3652.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i13.3652